Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

8 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33296678
DOI: 10.1016/j.cmet.2020.11.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver DiseasePMID 33296678Read ↗

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Gut microbiome-oriented therapy for metabolic diseases: challenges and opportunities towards clinical translationSemantic proximity Read ↗

The Intestinal Microbiome in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)Semantic proximity Read ↗

Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity Read ↗

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read ↗

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesSemantic proximity Read ↗

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

Gut microbiome-based medical methodologies for early-stage disease preventionSemantic proximity Read ↗

Gut microbiome and metabolic diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.